When people ask if you can reverse coronary disease...
— Ethan Weiss (@ethanjweiss) April 6, 2017
Regression of Coronary Atherosclerosis with Medical Therapy https://t.co/EdzxRSEqAb pic.twitter.com/VuHBMOPNwN
The case for a human knockout project: remarkably insightful #genomics study in a Pakistani cohort @Nature https://t.co/C9e7pDflFh pic.twitter.com/u2iZDrMoNe
— Eric Topol (@EricTopol) April 12, 2017
Nice review on targeting FGFR signalling in cancerhttps://t.co/S2ULULbWna$INCY $BPMC $LOXO $FPRX $HCM $ARQL pic.twitter.com/Hj1pjzbeb5
— Andy Biotech (@AndyBiotech) April 18, 2017
Subgroup findings in the abstracts of RCTs are rarely corroborated in further studies https://t.co/a83YFnVD9Y
— JAMAInternalMed (@JAMAInternalMed) April 21, 2017
Artificial womb article is published by Nature Communications. It's open and free. See the end for videos. https://t.co/ixdJM4w6a3
— Antonio Regalado (@antonioregalado) April 25, 2017
Shoutout to this NEJM paper on NSCLC tumor heterogeneity and genome evolution during the $BMY call. Tough disease. https://t.co/kIU3WMvfRp
— Brad Loncar (@bradloncar) April 27, 2017
Generation of inner ear organoids containing functional hair cells from human pluripotent stem cellshttps://t.co/WTLLTlEhzY pic.twitter.com/ZLbi7uL7Gd
— Andy Biotech (@AndyBiotech) May 2, 2017
Highly insightful+entertaining RNA delivery review by Dowdy available free online. Enjoy: https://t.co/I5uf7XZns5
— Dirk Haussecker (@RNAiAnalyst) May 3, 2017
NEW @NEJM @ChanaSacks @akesselheim: The Failure of @LillyPad Solanezumab — How the @US_FDA Saved Taxpayers Billions https://t.co/anQ5wNE5Ox pic.twitter.com/BboEI6yjxV
— PORTAL @ Harvard Med (@PORTAL_Research) May 3, 2017
Another great e.g. in @JAMA_current why we WILL ALWAYS NEED phase 3 trials in oncology & not just exag'd P2s https://t.co/OTOud83ByZ pic.twitter.com/78dqozbRh7
— Vinay Prasad (@VinayPrasad82) May 9, 2017